Genmab buys PDL Biopharma antibody plant for $240M

02/21/2008 | American City Business Journals

California-based PDL Biopharma completed the $240 million sale of its antibody manufacturing plant in Minnesota to Danish company Genmab A/S in a move to reduce its assets. The deal, which includes access to a leased development lab and other equipment, allows Genmab to supply clinical quantities of antibodies for PDL studies and retain the plant's 170 workers.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID